Enzo
is a New York-based biotechnology company that develops diagnostics tests for the treatment of cancer, diabetes, HIV, uveitis, and inflammatory bowel diseases... Read moreEnzo
is a New York-based biotechnology company that develops diagnostics tests for the treatment of cancer, diabetes, HIV, uveitis, and inflammatory bowel diseases... Read more
News
Mar 28, 2025
StreetInsider
Press Release: Enzo : Enzo Biochem Announces Notification to New York Stock Exchange of Intention to Voluntarily Delist Common Stock and Transfer Trading of Shares to OTCQX
Mar 20, 2025
Zacks
Enzo: ENZ Stock Down Following Q2 Earnings, Revenues Decline Y/Y
Mar 17, 2025
Owler
Enzo Biochem, Inc.: Enzo's revenue changed from $30.31M in Oct 2024 to $29.09M in Jan 2025
Mar 17, 2025
Yahoo
Enzo: Enzo Biochem: Fiscal Q2 Earnings Snapshot
Jan 17, 2025
Bank Info Security
Enzo: Biotech Firm to Pay $7.5M to Settle Lawsuit in 2023 Hack
Jan 15, 2025
Bloomberg Law
Enzo: Enzo Biochem to Pay $7.5 Million to Settle Suit Over 2023 Breach
Jan 14, 2025
GlobeNewswire
Press Release: Enzo : Enzo Biochem Receives Notice of Non-Compliance with New York Stock Exchange Listing Rules
Dec 19, 2024
Yahoo
Enzo: ENZ Stock Falls Post Q1 Earnings Amid Revenue and Demand Challenges
Dec 17, 2024
Owler
Enzo Biochem, Inc.: Enzo's revenue changed from $31.91M in Jul 2024 to $30.31M in Oct 2024
Dec 16, 2024
Marketscreener
Enzo: Enzo Biochem, Inc. Reports Earnings Results for the First Quarter Ended October 31, 2024
